Clinical trial
A Prospective, Multicenter, Within Subject Controlled Study to Evaluate the Effect of Apligraf in Nonhealing Wounds of Subjects With Junctional or Dystrophic Epidermolysis Bullosa
NCT00587223 is registered in ClinicalTrials.gov with Organogenesis as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Prospective, Multicenter, Within Subject Controlled Study to Evaluate the Effect of Apligraf in Nonhealing Wounds of Subjects With Junctional or Dystrophic Epidermolysis Bullosa
- Lead sponsor
- Organogenesis
- Phase
- Phase 3
- Overall status
- Terminated
- Start date
- December 31, 2007
- Completion date
- December 31, 2008
- Enrollment
- 1 (actual)
- Sites
- 5
Conditions
As the registry lists them; a condition with its own page is linked.